What is Aura Biosciences, Inc.'s operating lease liabilities?

Aura Biosciences, Inc. (AURA) reported operating lease liabilities of -$386K in Q1 2026.

How has Aura Biosciences, Inc.'s operating lease liabilities changed year-over-year?

Aura Biosciences, Inc.'s operating lease liabilities decreased by 18.8% year-over-year, from -$325K to -$386K.

What is the long-term trend for Aura Biosciences, Inc.'s operating lease liabilities?

Over 2 years (2023 to 2025), Aura Biosciences, Inc.'s operating lease liabilities has grown at a 2.6% compound annual growth rate (CAGR), from -$1.32M to -$1.39M.

Aura Biosciences, Inc. AURA Operating lease liabilities

Operating lease liabilities at other companies

UroGen PharmaURGN

——

Inhibrx Biosciences, Inc.INBX

——

ImmunomeIMNM

——

The Oncology Institute, Inc.TOI

——

ArriVent BioPharma, Inc.AVBP

——

Other financials

Income statement

See full

Operating income-$34.9M-20.1%

Net income-$33.7M-22.6%

EPS (diluted)-$0.50+9.1%

Balance sheet

See full

Cash & equivalents$84.8M+122%

Total debt$17.0M-7.9%

Total equity$107.2M-16.2%

Total assets$137.7M-11.4%

Cash flow

See full

Operating cash flow-$29.9M-28.0%

CapEx$102.0K-45.5%

Free cash flow-$30.0M-27.4%

Valuation

See full

Market cap$709.23M+89.4%

Enterprise value$641.43M+80.8%

Returns & leverage

See full

Return on equity-95.6%+222pp

Debt / equity0.2×0.0×

Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aura Biosciences, Inc.'s operating lease liabilities?: Aura Biosciences, Inc. (AURA) reported operating lease liabilities of -$386K in Q1 2026.
How has Aura Biosciences, Inc.'s operating lease liabilities changed year-over-year?: Aura Biosciences, Inc.'s operating lease liabilities decreased by 18.8% year-over-year, from -$325K to -$386K.
What is the long-term trend for Aura Biosciences, Inc.'s operating lease liabilities?: Over 2 years (2023 to 2025), Aura Biosciences, Inc.'s operating lease liabilities has grown at a 2.6% compound annual growth rate (CAGR), from -$1.32M to -$1.39M.